Impact Factor 3.845 | CiteScore 3.92
More on impact ›
Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology.
Further journal-wide criteria concerning natural product research and cancer research are detailed at this link, and unique criteria for the conception and review of submissions are facilitated also for individual Specialty Sections. Please check the`About`pages of each Specialty Section for further information.
Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Pharmacology is a medical science, as was recalled in the anniversary address for the 50th Spring Meeting in Mainz of the German Pharmacological Society in March 2009. This science, of the effect of medicinal bodies, gives us the handle to clarify the fundamental processes of life. It is also the science studying the interactions between chemicals and living beings directed to prevent, ameliorate or cure the deleterious consequences of their diseases, thereby providing medicine with weapons against diseases. Those major targets offer the opportunity to segment the field not only in studies considering pure basic topics but also by integrating basic and clinical science. This journal's editorial policy aims at identifying the most productive research projects through an evaluation by the scientific community and emphasizing proper use of translational science at both preclinical and clinical levels. Editors encourage collaboration between clinicians and basic scientists and welcome papers issued from a collaborative strategy between the academic and the private industrial sectors that could assist in the reversal of the current decline in the production of original medicines.
Frontiers in Pharmacology is a member of the Committee on Publication Ethics.
Frontiers in Pharmacology generally endorses the relevant principles described in the 4 pillars of ethnopharmacology for all studies involving natural products submitted to all specialty sections in the journal. Similarly, the journal generally endorses protocols including a minimum of 2 cell-lines in vitro as an evidential basis to demonstrate proposed anti-cancer effects in all relevant studies submitted to all specialty section in the journal. Further unique criteria for the conception and review of submissions are also facilitated - where appropriate - for individual specialty sections. Please check the`About`pages of each specialty section for further information.
Founding Field Chief Editor: Prof Theophile Godfraind
Short Name: Front. Pharmacol.
Electronic ISSN: 1663-9812
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS)
PMCID: all published articles receive a PMCID
Frontiers in Pharmacology is composed of the following Specialty Sections:
The specialty sections of Frontiers in Pharmacology welcome submission of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Study Protocol, Systematic Review, Technology and Code, Book Review, Policy and Practice Reviews, Curriculum, Instruction, and Pedagogy and Policy Brief.
When submitting a manuscript to Frontiers in Pharmacology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Pharmacology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org